GlaxoSmithKline Pharmaceuticals Limited GLAXO.NS
GLAXO.NS
GlaxoSmithKline Pharmaceuticals Limited LAURUSLABS.BO
Laurus Labs Limited LAURUSLABS.NS
Laurus Labs Limited GLAND.NS
Gland Pharma Limited GLAND.BO
Gland Pharma Limited ABBOTINDIA.NS
Abbott India Limited ABBOTINDIA.BO
Abbott India Limited BIOCON.BO
Biocon Limited BIOCON.NS
Biocon Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited LAURUSLABS.BO
Laurus Labs Limited LAURUSLABS.NS
Laurus Labs Limited GLAND.NS
Gland Pharma Limited GLAND.BO
Gland Pharma Limited ABBOTINDIA.NS
Abbott India Limited ABBOTINDIA.BO
Abbott India Limited BIOCON.BO
Biocon Limited BIOCON.NS
Biocon Limited GLENMARK.BO
Glenmark Pharmaceuticals Limited
Performance
| Periode | GLAXO.NS | LAURUSLABS.BO | LAURUSLABS.NS | GLAND.NS | GLAND.BO | ABBOTINDIA.NS | ABBOTINDIA.BO | BIOCON.BO | BIOCON.NS | GLENMARK.BO |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | -2.01 % | 44.30 % | 44.28 % | 31.28 % | 31.43 % | -2.13 % | -2.07 % | 10.17 % | 10.30 % | 35.55 % |
| YTD | 23.60 % | 50.21 % | 50.07 % | 6.21 % | 6.33 % | 0.78 % | 0.81 % | -0.84 % | -0.73 % | 14.97 % |
| 1Y | 4.35 % | 98.76 % | 98.58 % | 14.76 % | 14.78 % | 3.70 % | 3.69 % | 8.42 % | 8.51 % | 8.19 % |
| 3Y | 103.46 % | 89.53 % | 90.01 % | -12.22 % | -11.92 % | 63.30 % | 64.76 % | 36.10 % | 36.20 % | 366.08 % |
| 5Y | 82.04 % | 176.85 % | 176.74 % | 5.66 % | 5.71 % | 90.46 % | 90.44 % | -16.85 % | -16.72 % | 278.95 % |
| 10Y | 67.02 % | 861.34 % | 861.59 % | 5.66 % | 5.71 % | 446.58 % | 445.11 % | 385.27 % | 385.42 % | 81.98 % |
| From the beginning | 797.17 % | 861.34 % | 861.59 % | 5.66 % | 5.71 % | 3 649.07 % | 3 732.87 % | 806.10 % | 807.54 % | 8 869.07 % |